Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SAFETY AND EFFICACY OF FILGOTINIB IN ACTIVE RHEUMATOID ARTHRITIS BY PRIOR BIOLOGICAL DMARD EXPOSURE IN PATIENTS WITH PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) Genovese, M. C., Kalunian, K., Gottenberg, J., Mozaffarian, N., Bartok, B., Matzkies, F., Gao, J., Guo, Y., de Vlam, K., Walker, D., Takeuchi, T. BMJ PUBLISHING GROUP. 2019: 709–10
View details for DOI 10.1136/annrheumdis-2019-eular.1729
View details for Web of Science ID 000472207102135